Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Island Pharmaceuticals Ltd ( (AU:ILA) ) has issued an update.
Island Pharmaceuticals Ltd has applied for quotation on the ASX of 690,000 new ordinary fully paid shares, to be traded under its existing ticker ILA. The new securities, issued on March 23, 2026, modestly expand the company’s listed share base and may provide additional capital flexibility, though the announcement does not disclose specific use of proceeds or strategic initiatives linked to this issuance.
The most recent analyst rating on (AU:ILA) stock is a Hold with a A$0.45 price target. To see the full list of analyst forecasts on Island Pharmaceuticals Ltd stock, see the AU:ILA Stock Forecast page.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd is an Australia-listed pharmaceutical company trading under the ASX ticker ILA. The company operates in the biopharmaceutical sector, focusing on the development and commercialisation of drug products, with its shares listed as ordinary fully paid securities on the Australian Securities Exchange.
Average Trading Volume: 392,834
Technical Sentiment Signal: Buy
Current Market Cap: A$112M
See more insights into ILA stock on TipRanks’ Stock Analysis page.